Context
Cell Impact is a Swedish innovative industrial company specialized in flow plates for hydrogen PEM fuel cells and electrolyzers
Cell Impact sits at the heart of the fuel cells value chain, providing design, prototyping, and flow plates in serial production to fuel cells manufacturers and OEM
Its unique high-velocity impact forming technology (Cell Impact Forming©) solves the fuel cell industry challenge of cost and scale-up, in particular through CAPEX an OPEX reduction as well as a reduced use of power, water and other chemicals
Repositioned from 2018 to a flow plates designer and manufacturer, Cell Impact demonstrated growing commercial traction for its technology, incl. through first-class long-term collaboration with Plug Power, which signed a landmark SEK 42m purchase order in March 2021
On the back of such strong commercial momentum, Cell Impact needed to raise capital to finance further industrial scale
The rights issue aims to finance investments in new production space and equipment to ensure increased production capacity
About Cell Impact
Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell manufacturers. The company has developed and patented a unique method for high-velocity forming, Cell Impact Formingtm, which makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional forming methods.
The Cell Impact share is listed on Nasdaq First North Growth Market.
Deal Team
Should you want to know more about this transaction, you can contact one of the team members above
Bryan, Garnier & Co is proud to act as Joint Bookrunner to Cell Impact on its SEK 349m Rights Issue
Bryan, Garnier & Co acted as Joint Bookrunner in Cell Impact SEK 349m Rights Issue on Nasdaq First North Stockholm.
Bryan, Garnier & Co helped adjust and strengthen the equity story of the company, in the context of a recently disappointing hydrogen sector for European institutional investors.
Bryan, Garnier & Co also led a broad International NDR, targeting new Nordics and cont. Europe specialists and generalists institutions prior to the transaction in order to raise the profile of Cell Impact.
The fully guaranteed rights issue was multiple times oversubscribed, including with c. 95% of shareholders rights exercised, and stock performed well in the aftermarket with +22% offer to date
This is another landmark transaction in the Hydrogen value chain led by Bryan Garnier following the EUR 151m Hydrogène de France IPO, EUR 30m Enapter follow-on offering and EUR 180m McPhy re-IPO, and a further demonstration of the firm’s deep understanding of the Hydrogen ecosystem and the global energy transition / sustainability environment
Share